These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9150615)

  • 1. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia.
    Strittmatter M; Grauer M; Isenberg E; Hamann G; Fischer C; Hoffmann KH; Blaes F; Schimrigk K
    Headache; 1997 Apr; 37(4):211-6. PubMed ID: 9150615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia].
    Strittmatter M; Grauer M; Isenberg E; Hamann G; Fischer C; Hoffmann KH; Blaes F; Schimrigk K
    Schmerz; 1996 Oct; 10(5):261-8. PubMed ID: 12799848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trigeminal facial pain: a model of peptides and monoamines in intracerebral cerebrospinal fluid.
    Bouckoms AJ; Poletti CH; Sweet WH; Carr D; Keith D
    Agressologie; 1991; 32(5 Spec No):271-4. PubMed ID: 1722075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy.
    Strittmatter M; Isenberg E; Grauer MT; Hamann G; Schimrigk K
    Neurosci Lett; 1996 Nov; 218(2):99-102. PubMed ID: 8945737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide.
    Roy A; Lamparski D; De Jong J; Adinoff B; Ravitz B; George DT; Nutt D; Linnoila M
    Acta Psychiatr Scand; 1990 Jan; 81(1):58-61. PubMed ID: 1691893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia.
    Qin ZL; Yang LQ; Li N; Yue JN; Wu BS; Tang YZ; Guo YN; Lai GH; Ni JX
    Clin Neurol Neurosurg; 2016 Apr; 143():111-5. PubMed ID: 26918582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.
    Liu HC; Yang JC; Chang YF; Liu TY; Chi CW
    Ann N Y Acad Sci; 1991; 640():215-8. PubMed ID: 1723257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid variables among alcoholics lack seasonal variation.
    Roy A; Adinoff B; DeJong J; Linnoila M
    Acta Psychiatr Scand; 1991 Dec; 84(6):579-82. PubMed ID: 1724338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for heritability of biogenic amine levels in the cerebrospinal fluid of rhesus monkeys.
    Clarke AS; Kammerer CM; George KP; Kupfer DJ; McKinney WT; Spence MA; Kraemer GW
    Biol Psychiatry; 1995 Nov; 38(9):572-7. PubMed ID: 8573659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S; Abe T
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
    Martignoni E; Bono G; Blandini F; Sinforiani E; Merlo P; Nappi G
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):15-25. PubMed ID: 1712206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
    Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
    Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamines in the brain cerebrospinal fluid of facial pain patients.
    Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
    Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of monoamines and their metabolite contents in the cerebrospinal fluid of conscious rats.
    Wada Y; Egashira T; Takayama F; Yamanaka Y; Takada K; Takeda H; Matsumiya T
    Jpn J Pharmacol; 1998 Oct; 78(2):237-40. PubMed ID: 9829629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations.
    Strittmatter M; Grauer MT; Hamann GF; Cramer H; Schimrigk K
    Neurodegeneration; 1996 Dec; 5(4):359-66. PubMed ID: 9117548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients.
    Gislason T; Hedner J; Terenius L; Bisette G; Nemeroff CB
    Am Rev Respir Dis; 1992 Sep; 146(3):784-6. PubMed ID: 1381567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoaminergic transmitters in the cerebrospinal fluid of patients with acute, chronic, and intermittent pain. Interface between pain and depression?].
    Strittmatter M; Ostertag D; Hoffmann KH; Paulus C; Fischer C; Meyer S
    Nervenarzt; 2005 Apr; 76(4):443-52. PubMed ID: 15175858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.